Prevention of Antigenically Drifted Influenza by Inactivated and Live Attenuated Vacc

[Anne]

<!-- include file --> <!-- (do not remove) --> <center> <table border="0" cellpadding="0" cellspacing="0" width="640"> <tbody><tr valign="top"> <td>

<table border="0" cellpadding="0" cellspacing="0" width="640"> <tbody><tr> <td nowrap="nowrap" valign="top">Previous</td> <td align="center" valign="top"><table border="0" cellpadding="0" cellspacing="0"> <tbody><tr><th align="right" nowrap="nowrap" valign="top">Volume 355:2513-2522</th> <td nowrap="nowrap"></td> <th nowrap="nowrap" valign="top">December 14, 2006</th> <td nowrap="nowrap"></td> <th align="left" nowrap="nowrap" valign="top">Number 24</th> </tr></tbody></table></td> <td align="right" nowrap="nowrap" valign="top">Next</td> </tr> </tbody></table>

</td> </tr> </tbody></table> </center>

Prevention of Antigenically Drifted Influenza by Inactivated and Live Attenuated Vaccines

<center> Suzanne E. Ohmit, Dr.P.H., John C. Victor, Ph.D., M.P.H., Judy R. Rotthoff, R.N., Esther R. Teich, M.A., Rachel K. Truscon, M.P.H., Laura L. Baum, M.S., Bhavya Rangarajan, M.P.H., Duane W. Newton, Ph.D., Matthew L. Boulton, M.D., M.P.H., and Arnold S. Monto, M.D. </center>
<table style="width: 144px; height: 385px;" align="right" border="0" cellpadding="0" cellspacing="0"> <tbody><tr> <td width="20"> </td> <td bgcolor="#336699"> <table style="width: 138px; height: 416px;" border="0" cellpadding="0" cellspacing="1"> <tbody><tr valign="top"> <td align="center" bgcolor="#e8e8d1" width="200">

</td> </tr><tr> <td> <table bgcolor="#ffffff" border="0" cellpadding="2" cellspacing="0" width="100%"> <tbody><tr valign="top"><td colspan="2"></td></tr> <tr valign="top"><td align="center" valign="top" width="15">
</td><td valign="middle">
</td></tr> <tr valign="top"><td align="center" valign="top" width="15">
</td><td valign="middle">
</td></tr> <tr valign="top"><td align="center" valign="top" width="15">
</td><td valign="middle">
</td></tr> <tr valign="top"><td align="center" valign="top" width="15">
</td><td valign="middle">
</td></tr> <tr valign="top"><td align="center" valign="top" width="15">
</td><td valign="middle">
</td></tr> <tr><td colspan="2">
</td></tr><tr><td colspan="2">
</td></tr> <tr valign="top"><td colspan="2"></td></tr> </tbody></table> </td> </tr> <tr> <td align="center" bgcolor="#e8e8d1" width="200">

</td> </tr> <tr> <td> <table bgcolor="#ffffff" border="0" cellpadding="2" cellspacing="0" width="100%"> <tbody><tr valign="top"><td colspan="2"></td></tr> <tr valign="top"><td align="center" valign="top" width="15"></td><td valign="middle">Editorial</td></tr><tr valign="top"><td align="center" valign="top" width="15"></td><td valign="middle"><table border="0" cellpadding="0" cellspacing="0"><tbody><tr><td></td><td valign="middle">by Fukuda, K.</td></tr></tbody></table></td></tr> <tr valign="top"><td colspan="2"></td></tr> </tbody></table> </td> </tr> <tr> <td align="center" bgcolor="#e8e8d1" width="200">

</td> </tr> <tr> <td> <table style="width: 22px; height: 1px;" bgcolor="#ffffff" border="0" cellpadding="2" cellspacing="0"> <tbody><tr valign="top"><td colspan="2"></td></tr> <tr valign="top"><td align="center" valign="top" width="15"></td><td valign="middle">
</td></tr> <tr valign="top"><td align="center" valign="top" width="15"></td><td valign="middle">
</td></tr> <tr valign="top"><td align="center" valign="top" width="15"></td><td valign="middle">
</td></tr> <tr valign="top"><td align="center" valign="top" width="15"></td><td valign="middle">
</td></tr> <tr valign="top"><td align="center" valign="top" width="15"></td><td valign="middle">
</td></tr> <tr valign="top"><td colspan="2"></td></tr> </tbody></table> </td> </tr> <tr> <td align="center" bgcolor="#e8e8d1" width="200">

</td> </tr> <tr> <td> <table bgcolor="#ffffff" border="0" cellpadding="2" cellspacing="0" width="100%"> <tbody><tr valign="top"><td colspan="2">
</td></tr> <tr valign="top"><td align="center" valign="top" width="15">
</td><td valign="middle">
</td></tr> <tr valign="top"><td align="center" valign="top" width="15">
</td><td valign="middle">
</td></tr> <tr valign="top"><td colspan="2"></td></tr> </tbody></table> </td> </tr> </tbody></table> </td></tr></tbody></table> <!-- end of outer content box1 --> <!-- end of outer content box2 --> <!-- <CENTER> Prevention of Antigenically Drifted Influenza by Inactivated and Live Attenuated Vaccines

</CENTER> --> <!-- <CENTER> </NOBR><NOBR>Suzanne E. Ohmit, Dr.P.H.</NOBR>, <NOBR>John C. Victor, Ph.D., M.P.H.</NOBR>, <NOBR>Judy R. Rotthoff, R.N.</NOBR>, <NOBR>Esther R. Teich, M.A.</NOBR>, <NOBR>Rachel K. Truscon, M.P.H.</NOBR>, <NOBR>Laura L. Baum, M.S.</NOBR>, <NOBR>Bhavya Rangarajan, M.P.H.</NOBR>, <NOBR>Duane W. Newton, Ph.D.</NOBR>, <NOBR>Matthew L. Boulton, M.D., M.P.H.</NOBR> and <NOBR>Arnold S. Monto, M.D.</NOBR> </CENTER> --> ABSTRACT
Background The efficacy of influenza vaccines may decline duringyears when the circulating viruses have antigenically driftedfrom those included in the vaccine.
Methods We carried out a randomized, double-blind, placebo-controlledtrial of inactivated and live attenuated influenza vaccinesin healthy adults during the 2004?2005 influenza seasonand estimated both absolute and relative efficacies.
Results A total of 1247 persons were vaccinated between Octoberand December 2004. Influenza activity in Michigan began in January2005 with the circulation of an antigenically drifted type A(H3N2) virus, the A/California/07/2004-like strain, and of typeB viruses from two lineages. The absolute efficacy of the inactivatedvaccine against both types of virus was 77% (95% confidenceinterval [CI], 37 to 92) as measured by isolating the virusin cell culture, 75% (95% CI, 42 to 90) as measured by eitherisolating the virus in cell culture or identifying it throughreal-time polymerase chain reaction, and 67% (95% CI, 16 to87) as measured by either isolating the virus or observing arise in the serum antibody titer. The absolute efficacies ofthe live attenuated vaccine were 57% (95% CI, ?3 to 82),48% (95% CI, ?7 to 74), and 30% (95% CI, ?57 to67), respectively. The difference in efficacy between the twovaccines appeared to be related mainly to reduced protectionof the live attenuated vaccine against type B viruses.
Conclusions In the 2004?2005 season, in which most circulatingviruses were dissimilar to those included in the vaccine, theinactivated vaccine was efficacious in preventing laboratory-confirmedsymptomatic illnesses from influenza in healthy adults. Thelive attenuated vaccine also prevented influenza illnesses but<!-- HIGHWIRE EXLINK_ID="355:24:2513:1" VALUE="NCT00133523" TYPEGUESS="CLINTRIALGOV" -->was less efficacious. (ClinicalTrials.gov number, NCT00133523 [ClinicalTrials.gov]<!-- /HIGHWIRE --> .)


http://content.nejm.org/cgi/content/full/355/24/2513 here, the whole article